Similar companies
Income Statement (USD)
| Q4 '24 | QoQ | |
|---|---|---|
| Revenue | 31M | 50054.1% |
| Gross Profit | 2M | 111.1% |
| Cost of Revenue | 29M | 58% |
| Operating expense | 77M | 17.5% |
| Net Income | -45M | 26.9% |
Balance Sheet (USD)
| Q4 '24 | QoQ | |
|---|---|---|
| Total Assets | 342M | 4.3% |
| Total Liabilities | 207M | 36.5% |
| Total Equity | 134M | 23.5% |
| Shares Outstanding | 83M | 0.2% |
Cash Flow (USD)
| Q4 '24 | QoQ | |
|---|---|---|
| Cash from operations | -51M | 3.5% |
| Cash from investing | 31M | 63.1% |
| Cash from financing | 56M | 0% |
EPS
Financial Highlights for Editas Medicine in Q4 '24
Editas Medicine reported a revenue of 31M, which is a 50054.1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 2M, marking a 111.1% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 29M, a 58% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 77M, showing a 17.5% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -45M, showing a 26.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
It was a positive quarter for Editas Medicine with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
